The Bioinformatics Core was established in 2007 to provide analytical support for numerous research projects at the Joslin Diabetes Center. Core activities and resources including biostatistics consulting, the clinical data warehouse, the high-performance computer cluster and the analysis of genomic data have benefited most labs at Joslin. The recent emergence of new technologies for high-throughput DNA sequencing, metabolomics, and proteomics among others catalyzed transformative changes throughout the biomedical sciences. The need to introduce these whole genome technologies into diabetes research brings numerous informatics and systems biology challenges. Computational science, network modeling and informatics play important roles in meeting these challenges. We propose an expanded Computational Core that will significantly enhance our analytic capabilities in order to cover not only basic support functions but also to promote innovative network modeling and systems biology approaches to diabetes research at Joslin and throughout the Boston area. The proposed Core is named the Boston University Joslin Regional Computational Core (BUJRC Core) and will consist of two branches: the Bioinformatics / Computational Biology Service branch and the Collaborative Systems Biology/Medicine branch. The Bioinformatics / Computational Biology Service branch will act as a resource to the diabetes research community by providing state-of the-art analysis of high-throughput biomedical data, as well as consultation on the design of these types of experiments. This branch will support diabetes research in the design, analysis, and biological interpretation of experiments that involve generation of """"""""omic"""""""" data and its integration with physiological and clinical data. The Collaborative Systems Biology/Medicine branch will help to create an environment that incorporates computational systems biology/medicine methodologies into clinically relevant translational and basic diabetes research. This branch includes local faculty with a proven track record of having worked together to produce innovative systems biology and translational research. This proposed expanded Core will significantly enhance the prior capabilities to provide support functions to Joslin researchers as well as developing relevant network modeling and systems biology methodologies at Boston University. The expanded core will serve as a bridge for establishing collaborations with other diabetes researchers throughout the region.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK036836-28
Application #
8725126
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
28
Fiscal Year
2014
Total Cost
$318,217
Indirect Cost
$62,950
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Sustarsic, Elahu G; Ma, Tao; Lynes, Matthew D et al. (2018) Cardiolipin Synthesis in Brown and Beige Fat Mitochondria Is Essential for Systemic Energy Homeostasis. Cell Metab 28:159-174.e11
Karatepe, Kutay; Zhu, Haiyan; Zhang, Xiaoyu et al. (2018) Proteinase 3 Limits the Number of Hematopoietic Stem and Progenitor Cells in Murine Bone Marrow. Stem Cell Reports 11:1092-1105
Cardamone, Maria Dafne; Tanasa, Bogdan; Cederquist, Carly T et al. (2018) Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation. Mol Cell 69:757-772.e7
Lessard, Sarah J; MacDonald, Tara L; Pathak, Prerana et al. (2018) JNK regulates muscle remodeling via myostatin/SMAD inhibition. Nat Commun 9:3030
Stanford, Kristin I; Lynes, Matthew D; Takahashi, Hirokazu et al. (2018) 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. Cell Metab 27:1111-1120.e3
Solheim, Marie H; Winnay, Jonathon N; Batista, Thiago M et al. (2018) Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes. Diabetes 67:1297-1309
Weir, Gordon C; Ehlers, Mario R; Harris, Kristina M et al. (2018) Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics. Pediatr Diabetes 19:945-954
McGill, Dayna E; Volkening, Lisa K; Butler, Deborah A et al. (2018) Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes. Diabetes Technol Ther 20:434-439
Adachi, Yusuke; De Sousa-Coelho, Ana Luisa; Harata, Ikue et al. (2018) l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism. Mol Metab 17:61-70
Qi, Weier; Li, Qian; Gordin, Daniel et al. (2018) Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism. J Mol Med (Berl) 96:373-381

Showing the most recent 10 out of 1120 publications